Table 1.
Baseline Characteristics of Included Studies Reporting on Occurrence of Neoaortic Regurgitation
| First Author | Year | Location | Centers | Sample Size (n) | Time Period | Male, n (%) | Age at ASO, d | Weight at ASO, kg | VSD, n (%) | TBA, n (%) | AAA, n (%) | BPV, n (%) | NeoAR, n (%) | Follow-up (y) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bové et al19 | 2008 | Belgium | S | 93 | 1993-2006 | 66 (71) | 8 | 3.47 | 31 (33.3) | 8 (8.6) | 12 (12.9) | NA | 13 (14) | 4.8 ± 3.9 |
| Co-Vu et al30 | 2013 | USA | S | 124 | 1984-2007 | 85 (29) | 6 (3-1,800) | NA | 36 (49) | NA | 14 (19) | 7 (10) | 17 (14) | 7.2 (1-23) |
| Formigari et al31 | 2003 | Italy | M | 173 | 1987-2001 | 86 (50) | 8 (2-344) | 3.4 ± 9.6 | 33 (19) | 4 (2.3) | 8 (4.6) | 6 (3.5) | 61 (35) | 8.2 (0.6-11.2) |
| Hutter et al32 | 2001 | the Netherlands | S | 144 | 1977-2000 | NA | 8 (1-1,878) | NA | 47 (33) | 16 (11.1) | 9 (6.3) | 6 (4.2) | 5 (3.5) | 8.7 (0.1-22.5) |
| Irwin et al33 | 2021 | USA | S | 278 | 1989-2018 | 174 (63) | 8.2 ± 2.8 | NA | 139 (50) | NA | NA | 67 (24)a | 4 (4.2) | 11.3 (0.02-30.3) |
| Jeon et al34 | 2022 | Korea | S | 75 | 1997-2018 | 39 (52) | 12 [7-20] | 3.2 [2.8-3.6] | 45 (60) | 13 (17.3) | 0 (0) | 15 (25)a | NA | 9.9 (0.37-22.3) |
| Lange et al35 | 2008 | Germany | S | 479 | 1983-2006 | NA | 11 (2-4,928) | 3.5 (2.1-57) | 141 (29.4) | NA | 43 (9) | 21 (4) | 41 (8.7) | 9.3 (0-22.6) |
| Lim et al26 | 2013 | Korea | S | 220 | 1987-2011 | NA | 13 (0-1,768) | 3.52 (1.7-19) | 90 (40.9) | 17 (7.7) | NA | NA | 78 (38.0) | 8.6 (0-23.1) |
| Lo Rito et al4 | 2015 | United Kingdom | S | 362 | 1988-1998 | 264 (73) | 8 (1-3,905) | 3.45 (1.8-22.4) | 151 (41.7) | 30 (8.3) | 39 (10.8) | NA | 97 (45.8) | 16 [12-18.2] |
| Losay et al27 | 2001 | France | S | 1,095 | 1982-1999 | NA | 29 ± 93 | 3.5 ± 1.3 | 258 (23.6) | 67 (6.1) | 111 (10.1) | NA | 165 (15.5) | 4.9 ± 3.4 |
| Losay et al36 | 2006 | France | S | 1,156 | 1982-2000 | NA | 32.6 ± 142 | 3.5 ± 1.9 | 269 (23.3) | 72 (6.2) | 113 (9.8) | NA | 172 (14.9) | 6.25 (0-20) |
| Ma et al9 | 2016 | China | S | 583 | 2003-2013 | NA | 233 ± 654 | 3.1 ± 5.3 | 313 (53.7) | 0 (0) | 13 (2.2) | 14 (2.4) | 56 (10.4) | 3.83 (0.67-10) |
| Marino et al10 | 2006 | USA | S | 82 | 1984-1997 | 54 (66) | 5 (1-1,825) | NA | 30 (37) | NA | 8 (9.7) | NA | 69 (84.1) | 8.8 (4.1-16.4) |
| Martins et al11 | 2018 | Brazil | S | 127 | 1997-2015 | 90 (70.8) | NA | NA | 43 (33.9) | NA | 7 (5.5) | NA | 37 (29.1) | 7.4 ± 4.7 |
| Martins et al12 | 2019 | France | S | 157 | 2010-2017 | 108 (69) | 14.9 ± 30.9 | NA | 41 (26) | NA | 20 (13) | 8 (5.0) | 35 (22) | 14.9 ± 4.6 |
| McMahon et al13 | 2004 | USA | S | 119 | 1986-2001 | 75 (63) | 2 (2-37) | NA | 36 (30.3) | 10 (8.4) | 9 (7.6) | 0 (0.0) | 32 (27) | 5.42 (1-15) |
| Michalak et al14 | 2010 | Poland | S | 161 | 1991-2008 | 116 (72) | 9.79 ± 10.67 | 3.5 ± 1.3 | 52 (32) | NA | 0 (0) | 12 (7) | 75 (47) | 12.6 (10-18) |
| Michalak et al15 | 2013 | Poland | S | 172 | 1992-2011 | 122 (70) | 9.68 ± 9.45 | 3.37 ± 0.56 | 51 (28) | NA | 12 (7) | NA | 85 (49) | 13.5 ± 2.4 |
| Michalak et al16 | 2020 | Poland | S | 56 | 1991-2018 | NA | NA | NA | NA | NA | NA | NA | 30 (53.6) | 19.8 (17.9-23) |
| Muneuchi et al17 | 2022 | Japan | S | 45 | 1986-2019 | 34 (75.5) | 44.2 ± 39.8 | 3.51 ± 0.86 | 17 (37.7) | NA | 9 (20) | NA | 8 (17.8) | 21.7 ± 2.0 |
| Nakayama et al5 | 2019 | Japan | S | 469 | 1982-2016 | NA | 30.5 (3.1-2,486) | 3.5 (2.1-20.4) | 140 (29.9) | NA | 32 (6.8) | 9 (1.9) | 41 (8.6) | 19.0 (0.1-35.2) |
| Oda et al29 | 2012 | Japan | S | 387 | 1984-2010 | NA | 19 | NA | 98 (25.3) | NA | 52 (13.4) | 7 (1.8) | 29 (7.5) | 10 ± 7.4 |
| Oda et al18 | 2019 | Japan | S | 145 | 1984-2015 | 101 (69.7) | NA | NA | 46 (31.7) | NA | 19 (13.1) | 1 (0.7) | 21 (14.5) | 13.8 (11.9-17.9) |
| Prifti et al20 | 2002 | Italy | S | 134 | 1990-2001 | 79 (59) | NA | 4.8 ± 3.7 | 39 (29.1) | 8 (6.0) | 20 (15) | NA | 10 (7.5) | 3.4 (0.67-12) |
| Puras et al28 | 2014 | Spain | S | 155 | 1985-2010 | NA | 13 (4-4,015) | NA | 46 (29.7) | 5 (3.2) | 7 (4.5) | NA | 43 (28) | 6 (0-25) |
| Schwartz et al21 | 2004 | USA | S | 335 | 1981-2000 | 192 (66.9) | 6 (0-2,847) | 3.5 (1.5-31.9) | 151 (45.1) | NA | 47 (14.0) | 10 (3.0) | 17 (5.1) | >5 (0-18) |
| van der Palen et al37 | 2019 | the Netherlands | S | 345 | 1977-2015 | 229 (66.4) | 8 (0-219) | NA | 89 (25.8) | 26 (7.5) | 24 (7.0) | 21 (6.1) | 33 (9.6) | 12.2 (1-39) |
| W.K. Jhang et al25 | 2012 | Korea | S | 240 | 1991-2010 | 166 (69.1) | 11 (0-1,213) | 3.4 (1.3-18.8) | 100 (41.6) | 18 (7.5) | 16 (6.6) | 12 (5.0) | 6 (2.5) | 6.6 (1-19.5) |
| Walter et al23 | 2010 | Germany | S | 324 | 1987-2008 | 215 (66.3) | 6.3 ± 0.4 | 3.3 ± 0.5 | NA | NA | 6 (3) | NA | 17 (5.2) | 14.4 (1-17.8) |
| Wang et al24 | 2022 | China | S | 185 | 2006-2022 | 131 (70.8) | 24 ± 1,240 | 3.54 (2.2-7.3) | 64 (34.6) | 21 (11.4) | 11 (5.95) | 35 (18.67) | 19 (11.5) | 7.4 (0-15.6) |
Values presented as mean ± SD, median (range), median [IQR], and n/N (%) according to originally published data.
AAA = aortic arch anomalies; ASO = arterial switch operation; BPV = bicuspid pulmonary valve; NeoAR = neoaortic regurgitation; TBA = Taussig-Bing Anomaly; VSD = ventricular septal defect.
a
Bicuspid pulmonary valve groups were matched.